Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | FDPS | P14324 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PON1 | P27169 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6115333 | 0.98 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Fluoride Ion SCHEMBL1892964 | 0.98 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL17706397 | 0.90 | SMN1; SMN2 (0.43) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL16731564 | 0.81 | APAF1 (0.54) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL899258 | 0.80 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Bromide SCHEMBL6116136 | 0.79 | SMN1; SMN2 (0.56) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL17706400 | 0.79 | SMN1; SMN2 (0.43) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL425211 | 0.78 | — | — | |
| SCHEMBL20527541 | 0.78 | APAF1 (0.60) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL21821199 | 0.78 | APAF1 (0.60) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| EP-1960345-B1 | ALKYLATION OF N' -PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID, AND N' -PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | CHEMTURA CORP (US) | 2014-11-19 | — | — | EP | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| EP-1963253-B1 | RING ALKYLATION OF ANILINE OR AN ANILINE DERIVATIVE USING IONIC LIQUID CATALYSTS | CHEMTURA CORP (US) | 2011-01-05 | — | — | EP | claimed |
| EP-1960344-B1 | ALKYLATION OF A DIPHENYLAMINE COMPOUND IN IONIC LIQUID | CHEMTURA CORP (US) | 2010-09-29 | — | — | EP | claimed |
| US-7563929-B2 | Alkylation of N′-phenyl-N-alkylphenylenediamines in ionic liquid and N′-phenyl-N-alkyl(alkylphenylene) diamines produced thereby | CHEMTURA CORPORATION (US) | 2009-07-21 | — | — | US | claimed |
| US-20080234517-A1 | ALKYLATION OF N'-PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID AND N'-PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | CHEMTURA CORPORATION (US) | 2008-09-25 | — | — | US | claimed |
| EP-1963253-A2 | RING ALKYLATION OF ANILINE OR AN ANILINE DERIVATIVE USING IONIC LIQUID CATALYSTS | CHEMTURA CORPORATION (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1960345-A1 | ALKYLATION OF N' -PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID, N' -PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY, AND LUBRICANT COMPOSITIONS CONTAINING SAME | CHEMTURA CORPORATION (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1960344-A1 | ALKYLATION OF A DIPHENYLAMINE COMPOUND IN IONIC LIQUID | CHEMTURA CORPORATION (US) | 2008-08-27 | — | — | EP | claimed |
| US-7378554-B2 | Ring alkylation of aniline or an aniline derivative using ionic liquid catalysts | CHEMTURA CORPORATION (US) | 2008-05-27 | — | — | US | claimed |
| WO-2007070264-A1 | ALKYLATION OF A DIPHENYLAMINE COMPOUND IN IONIC LIQUID | CHEMTURA CORPORATION (US) | 2007-06-21 | — | — | WO | claimed |
| WO-2007070282-A1 | ALKYLATION OF N' -PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID, N' -PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY, AND LUBRICANT COMPOSITIONS CONTAINING SAME | CHEMTURA CORPORATION (US) | 2007-06-21 | — | — | WO | claimed |
| WO-2007070263-A2 | RING ALKYLATION OF ANILINE OR AN ANILINE DERIVATIVE USING IONIC LIQUID CATALYSTS | CHEMTURA CORPORATION (US) | 2007-06-21 | — | — | WO | claimed |
| US-20070135657-A1 | Alkylation of N'-phenyl-N-alkylphenylenediamines in ionic liquid, N'-phenyl-N-alkyl (alkylphenylene) diamines produced thereby, and lubricant compositions containing same | LANXESS SOLUTIONS US INC. | 2007-06-14 | — | — | US | claimed |
| US-20070135656-A1 | Ring alkylation of aniline or an aniline derivative using ionic liquid catalysts | LANXESS SOLUTIONS US INC. | 2007-06-14 | — | — | US | claimed |
| US-7145038-B1 | Alkylation of a diphenylamine compound in ionic liquid | CHEMTURA CORPORATION (US) | 2006-12-05 | — | — | US | claimed |
| CN-108409581-B | Preparation method of dinonyl-substituted diphenylamine antioxidant | 江苏飞亚化学工业有限责任公司 | 2020-07-14 | — | — | CN | disclosed |
| EP-1698606-A1 | FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND USING SAME | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234517-A1 | ALKYLATION OF N'-PHENYL-N-ALKYLPHENYLENEDIAMINES IN IONIC LIQUID AND N'-PHENYL-N-ALKYL(ALKYLPHENYLENE) DIAMINES PRODUCED THEREBY | PNMT, PNN, INMT | SMN1; SMN2 1972/4885MEN1 2662/4885APAF1 1493/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | SMN1; SMN2 4519/4885MEN1 1923/4885APAF1 4563/4885 |
| US-20070135657-A1 | Alkylation of N'-phenyl-N-alkylphenylenediamines in ionic liquid, N'-phenyl-N-alkyl (alkylphenylene) diamines produced thereby, and lubricant compositions containing same | NAPEPLD, PNN, ACR | SMN1; SMN2 2107/4885MEN1 3476/4885APAF1 1247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.